The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) metastatic breast cancer

Sudpreeda Chainitikun, James P. Long, Ruben Rodriguez-Bautista, Toshiaki Iwase, Debu Tripathy, Takeo Fujii, Naoto T. Ueno

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences